2023
DOI: 10.1016/j.jbc.2023.104841
|View full text |Cite
|
Sign up to set email alerts
|

Processive kinetics in the three-step lanosterol 14α-demethylation reaction catalyzed by human cytochrome P450 51A1

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
21
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

5
1

Authors

Journals

citations
Cited by 11 publications
(23 citation statements)
references
References 62 publications
2
21
0
Order By: Relevance
“…The synthesis of deuterated 14α-formyl 24,25-dihydrolanosterol (14α-CDO dihydrolanosterol) was based on work of Morisaki and associates, [26] which began with commercial 7-dehydrocholesterol and generated the protiated product in 14 steps to give the desired 14α-aldehyde. [27] The partially deuterated aldehyde was generated in three more steps by sequential Dess-Martin periodinane oxidation, [28] reduction with NaBD 4 , Dess-Martin periodinane oxidation, and Scheme 2. Oxidation of 24,25-dihydrolanosterol to 24,25-dihydro-4.4-dimethyl-5α-cholesta-8,14,24-trien-3β-ol (24,25-dihydro FF-MAS) and formic acid.…”
Section: O Labelingmentioning
confidence: 99%
See 3 more Smart Citations
“…The synthesis of deuterated 14α-formyl 24,25-dihydrolanosterol (14α-CDO dihydrolanosterol) was based on work of Morisaki and associates, [26] which began with commercial 7-dehydrocholesterol and generated the protiated product in 14 steps to give the desired 14α-aldehyde. [27] The partially deuterated aldehyde was generated in three more steps by sequential Dess-Martin periodinane oxidation, [28] reduction with NaBD 4 , Dess-Martin periodinane oxidation, and Scheme 2. Oxidation of 24,25-dihydrolanosterol to 24,25-dihydro-4.4-dimethyl-5α-cholesta-8,14,24-trien-3β-ol (24,25-dihydro FF-MAS) and formic acid.…”
Section: O Labelingmentioning
confidence: 99%
“…[27] As our 18 O labeling data clearly indicated the dominance of P450 Compound 0 (Figure 4), we were interested as to whether the proposed 14α-formyl lanosterol derivative (Baeyer-Villiger intermediate) was also a product under our experimental conditions, namely, utilizing a purified recombinant enzyme system (devoid of esterases in microsomes, which could degrade such an ester intermediate) and on-line LC-MS (which was not available to Fischer et al [12c] ). We performed a 14α-CDO dihydrolanosterol deformylation assay under steady-state conditions [27] and subjected the products of the reaction to reversed-phase (C 18 ) HPLC coupled to electrospray ionization (ESI) MS analysis. Our analysis revealed an NADPH-dependent chromatographic peak (t R 3.05 min) eluting as an early shoulder on the substrate peak (t R 3.51 min), corresponding to the chromatographic migration of the putative Baeyer-Villiger intermediate in the earlier report (Figures 6, S8).…”
Section: Kinetic Solvent Isotope Effect (Ksie) Analyses Are Unreliablementioning
confidence: 99%
See 2 more Smart Citations
“…The 18 O labeling approach that we have employed here is applicable to other P450-catalyzed oxidative deformylations, e.g., P450 19A1-catalyzed androstenedione aromatization (vide supra) and P450 51-catalyzed lanosterol 14α-demethylation. , Although Ortiz de Montellano and co-workers employed 18 O 2 to study an oxidative terminal side chain carbon cleavage reaction of cholesterol by bacterial P450 125A1, direct evidence of Compound 0 contribution was not presented, and this question could also be addressed by employing deuterium-labeled formic acid analysis. In principle, the approach can be applied to C–C bond scissions that yield acetic acid (e.g., P450 17A1-catalyzed 17α,20-lyase reaction and P450 1A2-catalyzed side-chain cleavage of nabumetone), , but with α-ketols, the 18 O labeling results are not unambiguous. ,, …”
mentioning
confidence: 99%